Welcome to our dedicated page for Chemed news (Ticker: CHE), a resource for investors and traders seeking the latest updates and insights on Chemed stock.
Chemed Corp (NYSE: CHE) delivers essential services through two core divisions: VITAS Healthcare, a leader in hospice and palliative care, and Roto-Rooter, the nation's largest plumbing and drain cleaning provider. This news hub provides timely updates on corporate developments, financial performance, and operational milestones across both sectors.
Investors and industry observers will find comprehensive coverage of earnings reports, strategic acquisitions, leadership changes, and regulatory updates. The page also tracks service expansions in end-of-life care programs and infrastructure maintenance innovations, offering insights into how Chemed maintains its dual-market leadership.
All content is curated to help stakeholders monitor the company's progress in healthcare compassion and technical service reliability. Bookmark this page for direct access to press releases, analyst commentaries, and market-moving announcements from Chemed Corporation.
Chemed (NYSE: CHE) reported strong Q1 2025 financial results with consolidated revenue increasing 9.8% to $646.9 million. The company's GAAP Diluted EPS rose 14.6% to $4.86, while Adjusted Diluted EPS grew 8.3% to $5.63.
VITAS Healthcare, their end-of-life care segment, showed remarkable growth with net patient revenue up 15.1% to $407.4 million, driven by a 13.1% increase in Average Daily Census and 7.3% growth in admissions. The recently acquired Covenant Health assets contributed approximately $11.5-12.5 million in revenue.
Roto-Rooter, their plumbing and drain cleaning segment, reported more modest growth with revenue increasing 1.8% to $239.5 million. However, the segment experienced mixed results across services, with commercial revenue up 7.3% but declining metrics in residential drain cleaning and plumbing.
As of March 31, 2025, Chemed maintained a strong financial position with $173.9 million in cash and no debt, while repurchasing 50,000 shares for $29.8 million during the quarter.
Chemed (NYSE: CHE) has scheduled its first-quarter 2025 earnings release for April 23, 2025, after the NYSE trading closes. The company will host a conference call and webcast on April 24, 2025, at 10 a.m. ET to discuss quarterly results and provide a business update.
Participants can access the event through Chemed's investor relations website or via teleconference registration. A replay will be available approximately two hours after the call through the company's website.
Chemed operates two main subsidiaries: VITAS Healthcare, the nation's largest provider of end-of-life hospice care, and Roto-Rooter, the leading provider of plumbing and drain cleaning services in the United States.
Chemed (NYSE:CHE) has announced its participation in the Oppenheimer 35th Annual Healthcare Conference scheduled for March 17, 2025, at 9:20 a.m. (ET). The presentation will be conducted virtually and will be accessible through a live webcast on the company's website at www.chemed.com.
The webcast replay will be available within 24 hours after the live presentation and remain accessible for 90 days. Headquartered in Cincinnati, Ohio, Chemed operates two major subsidiaries: VITAS Healthcare, the nation's largest provider of end-of-life hospice care, and Roto-Rooter, the leading provider of plumbing and drain cleaning services in the United States.
Chemed (NYSE: CHE) reported its Q4 2024 financial results, showing mixed performance across its two main segments. Consolidated revenue increased 9.2% to $640.0 million, with GAAP EPS rising 2.0% to $6.02 and Adjusted EPS up 3.5% to $6.83.
VITAS Healthcare, their hospice care division, demonstrated strong growth with revenue increasing 17.4% to $411.0 million, driven by a 14.6% increase in Average Daily Census and a 3.5% rise in Medicare reimbursement rates. The segment completed an $85.0 million acquisition of Covenant Health's hospice assets in April 2024.
Roto-Rooter segment showed declining performance with revenue decreasing 2.9% to $229.0 million and Adjusted EBITDA falling 7.2% to $60.3 million. The company's 2025 guidance projects earnings per diluted share of $24.95 to $25.45, compared to $23.13 in 2024.
Chemed (NYSE:CHE) has declared a quarterly cash dividend of 50 cents per share, maintaining the same level as the previous quarter's payment. The dividend will be paid on March 14, 2025, to shareholders of record as of February 24, 2025.
This marks Chemed's 215th consecutive quarterly dividend in its 53-year history as a public company. The company operates through two wholly owned subsidiaries: VITAS Healthcare, the nation's largest provider of end-of-life hospice care, and Roto-Rooter, the leading provider of plumbing and drain cleaning services in the United States.
Chemed (NYSE: CHE) has announced it will release its fourth-quarter 2024 financial results on February 26, 2025, after the NYSE trading close. The company will host a conference call and webcast on February 27, 2025, at 10 a.m. ET to discuss quarterly results and provide a business update.
Participants can access the event through Chemed's investor relations website or via teleconference registration. A replay will be available approximately two hours after the call through the company's website.
Chemed operates two main subsidiaries: VITAS Healthcare, the nation's largest provider of end-of-life hospice care, and Roto-Rooter, the leading provider of plumbing and drain cleaning services in the United States.
Chemed (NYSE:CHE) has announced its participation in the 43rd Annual JPMorgan Healthcare Conference. The presentation is scheduled for Tuesday, January 14, 2024, at approximately 10:30 a.m. PST and will take place at the Westin St. Francis Hotel in San Francisco, CA.
The event will be accessible through a live webcast on Chemed's website (www.chemed.com) under the Investor Relations section. A replay of the webcast will be available approximately three hours after the live presentation and will remain accessible for 90 days.
Chemed , headquartered in Cincinnati, Ohio, operates two major subsidiaries: VITAS Healthcare, the nation's largest provider of end-of-life hospice care, and Roto-Rooter, the country's leading provider of plumbing and drain cleaning services.
Chemed (NYSE:CHE) has announced its participation in the BofA Securities 2024 Virtual Home Care Conference scheduled for Tuesday, December 10, 2024, at 1:20 PM (ET). The presentation will be available via live webcast through Chemed's website and will remain accessible for 90 days after the event.
Chemed operates through two main subsidiaries: VITAS Healthcare, the nation's largest provider of end-of-life hospice care, and Roto-Rooter, the leading provider of plumbing and drain cleaning services in the United States. The company is headquartered in Cincinnati, Ohio, and is listed on the New York Stock Exchange.
Chemed (NYSE:CHE) has announced two significant financial decisions: First, its Board of Directors has authorized an additional $300 million for stock repurchase under the existing share repurchase program, to be funded through operational cash flow and revolving credit facility. Second, the board declared a quarterly cash dividend of 50 cents per share, payable on December 6, 2024, to shareholders of record as of November 18, 2024. This marks Chemed's 214th consecutive quarterly dividend in its 53-year history as a public company.
Chemed (NYSE: CHE) has announced its participation in the UBS 2024 Global Healthcare Conference. The presentation is scheduled for Tuesday, November 12, 2024, at 2:45 p.m. (ET) at the Terranea Resort in Rancho Palos Verdes, California. The event will be webcast live through Chemed's website, with presentation materials available online. A replay will be accessible within 24 hours and available for 90 days.
Chemed operates two main subsidiaries: VITAS Healthcare, the largest provider of end-of-life hospice care in the nation, and Roto-Rooter, the leading provider of plumbing and drain cleaning services.
